446 related articles for article (PubMed ID: 33299889)
1. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.
Yousef MH; El-Fawal HAN; Abdelnaser A
Biomed Res Int; 2020; 2020():9593254. PubMed ID: 33299889
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
Herceg Z; Paliwal A
Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
[TBL] [Abstract][Full Text] [Related]
3. [Progress of epigenetics and its therapeutic application in hepatocellular carcinoma].
Sun LY; Li XY; Sun ZW
Yi Chuan; 2015 Jun; 37(6):517-27. PubMed ID: 26351047
[TBL] [Abstract][Full Text] [Related]
4. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
Rivenbark AG; Coleman WB
Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087
[No Abstract] [Full Text] [Related]
5. Methylation profile as a new tool for classification of hepatocellular carcinoma.
Perret C
J Hepatol; 2011 Apr; 54(4):602-3. PubMed ID: 21145852
[No Abstract] [Full Text] [Related]
6. Epigenetics of hepatocellular carcinoma: a new horizon.
Liu WR; Shi YH; Peng YF; Fan J
Chin Med J (Engl); 2012 Jul; 125(13):2349-60. PubMed ID: 22882861
[TBL] [Abstract][Full Text] [Related]
7. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
[TBL] [Abstract][Full Text] [Related]
8. New Insights into the Epigenetics of Hepatocellular Carcinoma.
Wahid B; Ali A; Rafique S; Idrees M
Biomed Res Int; 2017; 2017():1609575. PubMed ID: 28401148
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways and related target therapies in liver carcinoma.
Tommasi S; Pinto R; Pilato B; Paradiso A
Curr Pharm Des; 2007; 13(32):3279-87. PubMed ID: 18045179
[TBL] [Abstract][Full Text] [Related]
10. Genetics and epigenetics of liver cancer.
Ozen C; Yildiz G; Dagcan AT; Cevik D; Ors A; Keles U; Topel H; Ozturk M
N Biotechnol; 2013 May; 30(4):381-4. PubMed ID: 23392071
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetic regulation and development of hepatocellular carcinoma].
Nishida N; Kudo M
Nihon Shokakibyo Gakkai Zasshi; 2016 May; 113(5):775-84. PubMed ID: 27151473
[No Abstract] [Full Text] [Related]
12. The Epigenetic Regulation of HCC Metastasis.
Han TS; Ban HS; Hur K; Cho HS
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544763
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on non-coding RNAs in the molecular pathogenesis of hepatocellular carcinoma].
Luo Z; Cui W
Zhonghua Gan Zang Bing Za Zhi; 2018 Oct; 26(10):797-800. PubMed ID: 30481892
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.
Yuan SX; Zhang J; Xu QG; Yang Y; Zhou WP
Cancer Lett; 2016 Sep; 379(2):239-44. PubMed ID: 26282784
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.
Kanda M; Sugimoto H; Kodera Y
World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
[TBL] [Abstract][Full Text] [Related]
17. Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma.
Ohata Y; Shimada S; Akiyama Y; Mogushi K; Nakao K; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Tanabe M; Tanaka S
Mol Cancer Ther; 2017 Jun; 16(6):1155-1165. PubMed ID: 28246302
[TBL] [Abstract][Full Text] [Related]
18. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].
He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080
[TBL] [Abstract][Full Text] [Related]
19. DYNLL1 is hypomethylated and upregulated in a tumor stage- and grade-dependent manner and associated with increased mortality in hepatocellular carcinoma.
Berkel C; Cacan E
Exp Mol Pathol; 2020 Dec; 117():104567. PubMed ID: 33171156
[TBL] [Abstract][Full Text] [Related]
20. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
